Abstract
Using a polyclonal antibody monospecific to the c‐erbB‐2 oncogene product, an immunohistochemical study on the expression of c‐erbB‐2 protein was performed in formalin‐fixed, paraffin‐embedded tissue sections from 176 primary breast carcinomas in which amplification of the c‐erbB‐2 gene had been detected in 28 cases. Expression of the c‐erbB‐2 protein was detected in 44 cases (25%), being strongly positive in 27 (15%) and weakly positive in 17 (10%). All cases with amplification of c‐erbB‐2 showed positive staining of its protein. There were only four cases in which c‐erbB‐2 was strongly expressed without amplification of the gene. In the group showing strongly positive staining, both overall and disease‐free survival were significantly poorer than in the remainder of the cases. Using Cox's regression model analysis, overexpression of c‐erbB‐2 protein was demonstrated to be an effective prognostic factor independent of nodal status or tumor size.
Keywords: Human breast cancer, c‐erbB‐2 protein, Amplification of c‐erbB‐2 gene, Immunohistochemistry, Prognostic factor
Full Text
The Full Text of this article is available as a PDF (340.5 KB).
REFERENCES
- 1. ) Yamamoto , T. , Ikawa , S. , Akiyama , T. , Semba , K. , Nomura , N , Miyajima , N. , Saito , T. and Toyoshima , K.Similarity of protein encoded by the human c‐erbB‐2 gene to epidermal growth factor receptor . Nature , 319 , 230 – 234 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Schechter , A. L. , Hung , M‐C , Vaidyanathan , L. , Weinberg , R. A. , Yang‐Feng , T. L. , Francke , U. , Ullrich , A. and Coussens , L.The neu gene: an erbB‐homologous gene distinct from and unlinked to the gene encoding the EGF receptor . Science , 229 , 976 – 978 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Coussens , L. , Yang‐Feng , T. L. , Liao , Y‐C , McGrath , J. , Seeburg , P. H. , Libermann , T. A. , Schlessinger , J. , Francke , U. , Levinson , A. and Ullrich , A.Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene . Science , 230 , 1132 – 1139 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 4. ) King , C. R. , Kraus , M. H. and Aaronson , S. A.Amplification of a novel v‐erbB‐related gene in a human mammary carcinoma . Science , 229 , 974 – 976 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Akiyama , T. , Sudo , C. , Ogawara , H. , Toyoshima , K. and Yamamoto , T.The product of the human c‐erbB‐2 gene: a 185‐kilodalton glycoprotein with tyrosine kinase activity . Science , 232 , 1644 – 1646 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Slamon , D. J. , Clark , G. M. , Wong , S. G. , Levin , W. J. , Ullrich , A. and McGuire , W. L.Human breast cancer: correlation of relapse and survival with amplification of the HER‐2/neu oncogene . Science , 235 , 177 – 182 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Slamon , D. J. , Godolphin , W. , Jones , L. A. , Holt , J. A. , Wong , S. G. , Keith , D. E. , Levin , W. J. , Stuart , S. G. , Udove , J. , Ullrich , A. and Press , M. F.Studies of the HER‐2/neu proto‐oncogene in human breast and ovarian cancer . Science , 244 , 707 – 712 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Yokota , J. , Yamamoto , T. , Miyajima , N. , Toyoshima , K. , Nomura , N. , Sakamoto , H. , Yoshida , T. , Terada , M. and Sugimura , T.Genetic alterations of the c‐erbB‐2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v‐erbA‐homologue . Oncogene , 2 , 283 – 287 ( 1988. ). [PubMed] [Google Scholar]
- 9. ) Tsuda , H. , Hirohashi , S. , Shimosato , Y. , Hirota , T. , Tsugane , S. , Yamamoto , H. , Miyajima , N. , Toyoshima , K. , Yamamoto , T. , Yokota , J. , Yoshida , T. , Sakamoto , H. , Terada , M. and Sugimura , T.Correlation between long‐term survival in breast cancer patients and amplification of two putative oncogene‐coamplification units: hst‐1/int‐2 and c‐erbB‐2/ear‐1 . Cancer Res. , 49 , 3104 – 3108 ( 1989. ). [PubMed] [Google Scholar]
- 10. ) Wright , C. , Angus , B. , Nicholson , S. , Sainsbury , J. R. C. , Cairns , J. , Gullick , W. J. , Kelly , P. , Harris , A. L. and Horne , C. H. W.Expression of c‐erbB‐2 oncoprotein: a prognostic indicator in human breast cancer . Cancer Res. , 49 , 2087 – 2090 ( 1989. ). [PubMed] [Google Scholar]
- 11. ) Guérin , M. , Gabillot , M , Mathieu , M‐C. , Travagli , J‐P. , Spielmann , M. , Andrieu , N. and Riou , G.Structure and expression of c‐erbB‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: prognostic significance . Int. J. Cancer , 43 , 201 – 208 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Yamada , Y. , Yoshimoto , M. , Murayama , Y. , Ebuchi , M. , Mori , S. , Yamamoto , T. , Sugano , H. and Toyoshima , K.Association of elevated expression of the c‐erbB‐2 protein with spread of breast cancer . Jpn. J. Cancer Res. , 80 , 1192 – 1198 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. ) Hsu , S‐M. , Raine , M. and Fanger , H.Use of avidin‐biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures . J. Histochem. Cytochem. , 29 , 577 – 580 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Kaplan , E. L. and Meier , P.Nonparametric estimation from incomplete observations . J. Am. Stat. Assoc. , 53 , 457 – 481 ( 1958. ). [Google Scholar]
- 15. ) Peto , R. , Pike , M. C. , Armitage , P. , Breslow , N. E. , Cox , D. R. , Howard , S. V. , Mantel , N. , McPherson , K. , Peto , J. and Smith , P. G.Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples . Br. J. Cancer , 35 , 1 – 39 ( 1977. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. ) Cox , D. R.Regression models and life‐tables . J. R. Stat. Soc. , 34 , 187 – 220 ( 1972. ). [Google Scholar]
- 17. ) Harrell , F. E. , Jr.The PHGLM procedure . In “ Supplementary Library User's Guide ,” ed. Hastings R. P. , pp. 267 – 294 ( 1983. ). SAS Institute Inc. , Cary . [Google Scholar]
- 18. ) van de Vijver , M. J. , Peterse , J. L. , Mooi , W. J. , Wisman , P. , Lomans , J. , Dalesio , O. and Nusse , R.neu‐protein overexpression in breast cancer: association with comedo‐type ductal carcinoma in situ and limited prognostic value in stage II breast cancer . N. Engl. J. Med. , 319 , 1239 – 1245 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Gusterson , B. A. , Machin , L. G. , Gullick , W. J. , Gibbs , N. M. , Powles , T. J. , Elliott , C. , Ashley , S. , Monaghan , P. and Harrison , S.c‐erbB‐2 expression in benign and malignant breast disease . Br. J. Cancer , 58 , 453 – 457 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. ) Barnes , D. M. , Lammie , G. A. , Millis , R. R. , Gullick , W. L. , Allen , D. S. and Altman , D. G.An immunohistochemical evaluation of c‐erbB‐2 expression in human breast carcinoma . Br. J. Cancer , 58 , 448 – 452 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. ) Berger , M. S. , Locher , G. W. , Saurer , S. , Gullick , W. J. , Waterfield , M. D. , Groner , B. and Hynes , N. E.Correlation of c‐erbB‐2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading . Cancer Res. , 48 , 1238 – 1243 ( 1988. ). [PubMed] [Google Scholar]
- 22. ) Ali , I. U. , Campbell , G. , Lidereau , R. and Callahan , R.Amplification of c‐erbB‐2 and aggressive human breast tumors ? Science , 240 , 1795 – 1796 ( 1988. ). 3289120 [Google Scholar]
- 23. ) Bargmann , C. I. and Weinberg , R. A.Oncogenic activation of the neu‐encoded receptor protein by point mutation and deletion . EMBO J. , 7 , 2043 – 2052 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]